Sepsis and
metabolic syndrome (MetS) are both
inflammation-related entities with high impact for human health and the consequences of concussions. Both represent imbalanced parasympathetic/
cholinergic response to insulting triggers and variably uncontrolled
inflammation that indicates shared upstream regulators, including short
microRNAs (miRs) and long non-coding RNAs (lncRNAs). These may cross talk across multiple systems, leading to complex molecular and clinical outcomes. Notably, biomedical and
RNA-sequencing based analyses both highlight new links between the acquired and inherited pathogenic, cardiac and inflammatory traits of
sepsis/MetS. Those include the HOTAIR and MIAT lncRNAs and their targets, such as miR-122, -150, -155, -182, -197, -375, -608 and
HLA-DRA. Implicating
non-coding RNA regulators in
sepsis and MetS may delineate novel high-value
biomarkers and targets for intervention.